Form D · Biotechnology
PROFECTUS BIOSCIENCES, INC
Baltimore, MD · CIK 0001444253
Offering snapshot reported Dec 12, 2016 · SEC filing
- Reported sold
- $300K Offering amount: $4M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- May 5, 2016 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 12, 2016 | Amendment | $300,000 | $0vs May 13, 2016 | 5 | SEC filing |
| May 13, 2016 | Initial | $300,000 | No comparison | 5 | SEC filing |
| Aug 4, 2014 | Amendment | $7,541,206 | $250,000vs Apr 17, 2014 | 1 | SEC filing |
| Apr 17, 2014 | Amendment | $7,291,206 | $250,000vs Aug 13, 2013 | 1 | SEC filing |
| Aug 13, 2013 | Amendment | $7,041,206 | $2,000,001vs Jul 28, 2009 | 1 | SEC filing |
| Feb 11, 2013 | Amendment | $7,041,206 | $250,000vs Jul 18, 2011 | 1 | SEC filing |
| Jul 18, 2011 | Amendment | $6,791,206 | $1,750,001vs Jul 28, 2009 | 1 | SEC filing |
| Apr 6, 2010 | Amendment | $6,041,205 | $1,000,000vs Jul 28, 2009 | 1 | SEC filing |
| Jul 28, 2009 | Initial | $5,041,205 | No comparison | 1 | SEC filing |
| Aug 28, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Option to acquire, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-263137
Convertible debt
Source: Form D, filed Dec 12, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brian K. Adamsky | Director |
| Joseph Berardino | Director |
| Donald Caldwell | Director |
| Stewart J. Greenebaum | Director |
| Michael Greenebaum | Director |
| William Haseltine | Director |
| Reinhard A. Kurth | Director |
| Terry Lierman | Director |
| Thomas A. Lynch | Director |
| Jeffrey N. Meshulam | Director, Executive |
| Shawn Patrick O'brien | Director, Executive |
| Thomas G. Paese | Executive |
| Tom Pease | Executive |
| Thomas G. Pease | Director, Executive |
| Alexander G. Rich | Director, Executive |
| M.G. Sarngadharan | Director |
| M.G. Sarngaharan | Executive |
| Jeffrey Stello | Executive |
| Frederick C. Tecce | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:Baltimore, MD, 21224